Cargando…

Targeting NLRP3 Inflammasome in the Treatment Of Diabetes and Diabetic Complications: Role of Natural Compounds from Herbal Medicine

Diabetes, a common metabolic disease with various complications, is becoming a serious global health pandemic. So far there are many approaches in the management of diabetes; however, it still remains irreversible due to its complicated pathogenesis. Recent studies have revealed that nucleotide-bind...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bai, Ying, Mu, Qianqian, Bao, Xueli, Zuo, Jiacheng, Fang, Xin, Hua, Jing, Zhang, Dongwei, Jiang, Guangjian, Li, Ping, Gao, Sihua, Zhao, Dandan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	JKL International LLC 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8460305/ https://www.ncbi.nlm.nih.gov/pubmed/34631209 http://dx.doi.org/10.14336/AD.2021.0318

Ejemplares similares

Anti-Diabetic Effects of Jiang Tang Xiao Ke Granule via PI3K/Akt Signalling Pathway in Type 2 Diabetes KKAy Mice
por: Yu, Na, et al.
Publicado: (2017)

Protective Effect of Jiang Tang Xiao Ke Granules against Skeletal Muscle IR via Activation of the AMPK/SIRT1/PGC-1α Signaling Pathway
por: Bai, Ying, et al.
Publicado: (2021)

Ginsenoside Rb1, salvianolic acid B and their combination modulate gut microbiota and improve glucolipid metabolism in high-fat diet induced obese mice
por: Bai, Ying, et al.
Publicado: (2021)

Anti-NLRP3 Inflammasome Natural Compounds: An Update
por: Liu, Baolong, et al.
Publicado: (2021)

Role of NLRP3 inflammasome in diabetes and COVID-19 role of NLRP3 inflammasome in the pathogenesis and treatment of COVID-19 and diabetes NLRP3 inflammasome in diabetes and COVID-19 intervention
por: Zhang, Jiayu, et al.
Publicado: (2023)

NLRP3 Inflammasome Polymorphism and Macrovascular Complications in Type 2 Diabetes Patients
por: Klen, Jasna, et al.
Publicado: (2015)

Emerging Role of LncRNA Regulation for NLRP3 Inflammasome in Diabetes Complications
por: Lu, Xiaolin, et al.
Publicado: (2022)

Modulatory Mechanisms of the NLRP3 Inflammasomes in Diabetes
por: Ding, Sujuan, et al.
Publicado: (2019)

Catalpol in Diabetes and its Complications: A Review of Pharmacology, Pharmacokinetics, and Safety
por: Bai, Ying, et al.
Publicado: (2019)

NLRP3 Inflammasome in Diabetic Cardiomyopathy and Exercise Intervention
por: Sun, Yi, et al.
Publicado: (2021)

The Role of NLRP3 Inflammasome Signaling on Arrhythmias in Diabetes
por: Zhang, Lei, et al.
Publicado: (2022)

Natural Compounds as Regulators of NLRP3 Inflammasome-Mediated IL-1β Production
por: Tőzsér, József, et al.
Publicado: (2016)

NLRP3 Inflammasome/Pyroptosis: A Key Driving Force in Diabetic Cardiomyopathy
por: Zhang, Lixia, et al.
Publicado: (2022)

Aloe-Emodin Derivative, an Anthraquinone Compound, Attenuates Pyroptosis by Targeting NLRP3 Inflammasome in Diabetic Cardiomyopathy
por: Hu, Yingying, et al.
Publicado: (2023)

Jiang Tang Xiao Ke Granule Protects Hepatic Tissue of Diabetic Mice Through Modulation of Insulin and Ras Signaling – A Bioinformatics Analysis of MicroRNAs and mRNAs Network
por: Bai, Ying, et al.
Publicado: (2020)

NLRP3 Inflammasome as a Molecular Marker in Diabetic Cardiomyopathy
por: Luo, Beibei, et al.
Publicado: (2017)

The Role of H(2)S Regulating NLRP3 Inflammasome in Diabetes
por: Zhao, Huijie, et al.
Publicado: (2022)

Characterization of NLRP3 Inflammasome Activation in the Onset of Diabetic Retinopathy
por: Kuo, Charisse Y-J., et al.
Publicado: (2022)

Oxidative Stress and NLRP3-Inflammasome Activity as Significant Drivers of Diabetic Cardiovascular Complications: Therapeutic Implications
por: Sharma, Arpeeta, et al.
Publicado: (2018)

Potential therapeutic role of pyroptosis mediated by the NLRP3 inflammasome in type 2 diabetes and its complications
por: Li, Xiang, et al.
Publicado: (2022)

Natural products in attenuating renal inflammation via inhibiting the NLRP3 inflammasome in diabetic kidney disease
por: Wang, Yan, et al.
Publicado: (2023)

Small RNA Sequencing Analysis of STZ-Injured Pancreas Reveals Novel MicroRNA and Transfer RNA-Derived RNA with Biomarker Potential for Diabetes Mellitus
por: Mo, Fangfang, et al.
Publicado: (2023)

Astragaloside IV attenuates gestational diabetes mellitus via targeting NLRP3 inflammasome in genetic mice
por: Zhang, Ruixue, et al.
Publicado: (2019)

Upregulated NLRP3 Inflammasome Activation in Patients With Type 2 Diabetes
por: Lee, Hye-Mi, et al.
Publicado: (2013)

Nlrp3 Inflammasome Activation in Type 2 Diabetes: Is It Clinically Relevant?
por: Dixit, Vishwa Deep
Publicado: (2013)

Curcumin Ameliorates Diabetic Nephropathy by Suppressing NLRP3 Inflammasome Signaling
por: Lu, Miaomiao, et al.
Publicado: (2017)

NLRP3 inflammasome promotes diabetes-induced endothelial inflammation and atherosclerosis
por: Wan, Zhaofei, et al.
Publicado: (2019)

The Role of the Effects of Endoplasmic Reticulum Stress on NLRP3 Inflammasome in Diabetes
por: Lv, Shuangyu, et al.
Publicado: (2021)

The Role of NLRP3 Inflammasome in Diabetic Cardiomyopathy and Its Therapeutic Implications
por: Ding, Kai, et al.
Publicado: (2022)

The mechanisms of NLRP3 inflammasome/pyroptosis activation and their role in diabetic retinopathy
por: Zheng, Xiaoqin, et al.
Publicado: (2023)

NLRP3-mediated pyroptosis in diabetic nephropathy
por: Wan, Jiayi, et al.
Publicado: (2022)

Effect of sericin on the p38MAPK signaling pathway and NLRP3 inflammasome in the kidney of type 2 diabetic rats
por: Liu, Donghui, et al.
Publicado: (2020)

The NLRP6 inflammasome
por: Zheng, Danping, et al.
Publicado: (2020)

Natural Products that Target the NLRP3 Inflammasome to Treat Fibrosis
por: Ding, Nan, et al.
Publicado: (2020)

NLRP3 inflammasome as a potential treatment in ischemic stroke concomitant with diabetes
por: Hong, Pu, et al.
Publicado: (2019)

NLRP3 Inflammasome at the Interface of Inflammation, Endothelial Dysfunction, and Type 2 Diabetes
por: Gora, Ilona M., et al.
Publicado: (2021)

The Role of the NLRP3 Inflammasome in Mediating Glomerular and Tubular Injury in Diabetic Nephropathy
por: Williams, B. M., et al.
Publicado: (2022)

EFFECT OF HERBAL COMPOUND ON MATURITY ONSET DIABETES
por: Jain, A. K., et al.
Publicado: (1987)

NLRP3 inflammasome in endothelial dysfunction
por: Bai, Baochen, et al.
Publicado: (2020)

Metformin Inhibits the NLRP3 Inflammasome via AMPK/mTOR-dependent Effects in Diabetic Cardiomyopathy
por: Yang, Fan, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_p990opmjgj0jr1l88r006ec20m